Medicover AB (publ) (STO:MCOV.B)
Sweden · Delayed Price · Currency is SEK 203.00
-6.00 (-2.87%)
At close: May 8, 2026
Medicover AB Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 79.5 | 77.5 | 16.7 | 17.6 | 11.8 | 101.8 |
Depreciation & Amortization | 201.1 | 197.1 | 183.1 | 170.2 | 149.7 | 104.2 |
Other Amortization | 17.5 | 17.5 | 15.1 | 12.4 | 9.5 | 6.8 |
Asset Writedown & Restructuring Costs | 0.7 | 0.7 | 16.4 | -0.2 | 2.7 | - |
Loss (Gain) From Sale of Investments | - | - | - | - | 1.3 | -0.4 |
Stock-Based Compensation | 14.7 | 15.4 | 12.2 | 9.4 | 9.6 | 6.4 |
Other Operating Activities | 50.5 | 40.6 | 36.4 | 10 | 25.2 | 38.8 |
Change in Accounts Receivable | -66.6 | -53.4 | -53.3 | -29.1 | -26.7 | -49.5 |
Change in Inventory | -4.6 | -1 | -8.2 | -5.1 | 12.7 | -17.1 |
Change in Accounts Payable | 36.1 | 49.3 | 43.5 | 19.8 | -25.6 | 25.7 |
Operating Cash Flow | 328.9 | 343.7 | 261.9 | 205 | 170.2 | 216.7 |
Operating Cash Flow Growth | 21.41% | 31.23% | 27.76% | 20.45% | -21.46% | 39.72% |
Capital Expenditures | -156 | -158.1 | -122.3 | -110.5 | -140.6 | -102.2 |
Sale of Property, Plant & Equipment | 1 | 1 | 2.2 | 1.4 | 3 | 2.1 |
Cash Acquisitions | -170.5 | -174.6 | -18.1 | -19.6 | -229.1 | -87.5 |
Divestitures | - | - | - | 14 | - | - |
Investment in Securities | 3.3 | 2.6 | -2.3 | -1.6 | 180.1 | -144.2 |
Other Investing Activities | 7 | 7 | 5.7 | 4 | 1.8 | 1 |
Investing Cash Flow | -315.1 | -322.1 | -134.7 | -119.8 | -184.8 | -333.6 |
Long-Term Debt Issued | - | 945.2 | 884.8 | 461.9 | 524.1 | 293.7 |
Long-Term Debt Repaid | - | -859.1 | -829.2 | -462.8 | -485.3 | -93.2 |
Net Debt Issued (Repaid) | 69.5 | 86.1 | 55.6 | -0.9 | 38.8 | 200.5 |
Issuance of Common Stock | - | - | - | 0.3 | - | 0.3 |
Repurchase of Common Stock | - | - | - | -0.3 | - | -0.3 |
Common Dividends Paid | -22.5 | -22.5 | -18 | -17.9 | -17.8 | -10.4 |
Other Financing Activities | -68.4 | -69.4 | -145.6 | -54.9 | -45.3 | -26 |
Financing Cash Flow | -21.4 | -5.8 | -108 | -73.7 | -24.3 | 164.1 |
Foreign Exchange Rate Adjustments | -2.8 | -3.3 | -0.2 | -1.1 | -2.6 | -12 |
Net Cash Flow | -10.4 | 12.5 | 19 | 10.4 | -41.5 | 35.2 |
Free Cash Flow | 172.9 | 185.6 | 139.6 | 94.5 | 29.6 | 114.5 |
Free Cash Flow Growth | 16.59% | 32.95% | 47.73% | 219.26% | -74.15% | 38.62% |
Free Cash Flow Margin | 7.13% | 7.80% | 6.67% | 5.41% | 1.96% | 8.31% |
Free Cash Flow Per Share | 1.14 | 1.23 | 0.93 | 0.63 | 0.20 | 0.77 |
Cash Interest Paid | 62.2 | 60.7 | 59.4 | 46.5 | 32.4 | 19.7 |
Cash Income Tax Paid | 34.9 | 38.5 | 19.2 | 28.8 | 19.1 | 18.3 |
Levered Free Cash Flow | 136.71 | 137.34 | 99.25 | 70.86 | 56.68 | 90.66 |
Unlevered Free Cash Flow | 177.59 | 177.34 | 136 | 102.99 | 78.24 | 103.23 |
Change in Working Capital | -35.1 | -5.1 | -18 | -14.4 | -39.6 | -40.9 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.